News
Pfizer's Paxlovid antiviral drug lowered risk of long Boston Heraldwww.bostonherald.com › › pfizers-paxlovid-antiviral-drug-lo...
www.bostonherald.com
4 days ago · ... are more prone to bias than a randomized trial, said Bob Wachter, chair of medicine at the University of California, San Francisco.
Pfizer's Paxlovid antiviral drug lowered risk of long Star Tribunewww.startribune.com › pfizer-s-paxlovid-antiviral-drug-lowered-risk-of-lo...
www.startribune.com
4 days ago · ... are more prone to bias than a randomized trial, said Bob Wachter, chair of medicine at the University of California, San Francisco.
Pfizer's Paxlovid anti-viral seen to lower long-COVID risk in studywww.japantimes.co.jp › news › › world › science-health-world
www.japantimes.co.jp
4 days ago · ... are more prone to bias than a randomized trial, said Bob Wachter, chair of medicine at the University of California, San Francisco.
UCSF's Dr. Bob Wachter on why he's masking again - SFGATEwww.sfgate.com › bayarea › article › UCSF-Dr-Bob-Wachter-is-putting-his...
www.sfgate.com
May 3, · Dr. Bob Wachter is the chair of UCSF's Department of Medicine ...
sorted by relevance / date